Suraksha Diagnostic Ltd reports Q2 FY27 revenue of ₹99.1 crore, up 25.8% YoY, and PAT of ₹15.0 crore
- EBITDA was ₹36.3 crore, with a 36.7% margin, up 45.5% YoY.
- PAT margin was 15.1%; no exceptional items were reported.
- Investor presentation covers unaudited standalone and consolidated Q2 and H1 FY27 results, operating metrics and network expansion.
